|
EIF5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63513647066793E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.02995389994476E-12 |
| Normal-vs-Stage2 |
1.027130E-04 |
| Normal-vs-Stage3 |
1.9639845305619E-12 |
| Normal-vs-Stage4 |
4.14990264374637E-12 |
| Stage1-vs-Stage2 |
2.003000E-01 |
| Stage1-vs-Stage3 |
8.975700E-02 |
| Stage1-vs-Stage4 |
3.164200E-02 |
| Stage2-vs-Stage3 |
3.313600E-02 |
| Stage2-vs-Stage4 |
1.235780E-02 |
| Stage3-vs-Stage4 |
4.589000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
2.99439999995599E-06 |
| Normal-vs-Asian |
1.72720000524151E-08 |
| Caucasian-vs-AfricanAmerican |
7.421000E-01 |
| Caucasian-vs-Asian |
3.227800E-01 |
| AfricanAmerican-vs-Asian |
6.941600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.67360031283681E-10 |
| Normal-vs-Female |
1.63524749297039E-12 |
| Male-vs-Female |
7.861800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.86306525762348E-12 |
| Normal-vs-Age(41-60Yrs) |
9.15939546430877E-11 |
| Normal-vs-Age(61-80Yrs) |
3.13240544613791E-11 |
| Normal-vs-Age(81-100Yrs) |
3.835300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.609800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.919000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.792200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.411600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.787600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.856200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.421700E-03 |
| Classical-VS-Follicular |
1.180330E-02 |
| Classical-VS-Other |
1.735600E-01 |
| Classical-VS-Normal |
1.24550036950666E-10 |
| Tall-VS-Follicular |
3.83310000000581E-05 |
| Tall-VS-Other |
9.536400E-01 |
| Tall-VS-Normal |
5.45119505090952E-13 |
| Follicular-VS-Other |
1.040980E-01 |
| Follicular-VS-Normal |
3.035100E-04 |
| Other-VS-Normal |
2.620500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.38569999919014E-09 |
| Normal-vs-N1 |
1.0991207943789E-14 |
| N0-vs-N1 |
5.95369999999429E-05 |
|
|
